CTC Clinical Trial Consultants AB
- Address
- lock Available on a paid plan
Nutritional and Metabolic Diseases
The research at CTC Clinical Trial Consultants AB emphasizes conditions such as obesity and overweight, seeking to test new therapies that support weight reduction and improve metabolic health.
- Appetite regulation strategies
- Energy balance and metabolic rate studies
- Pharmacokinetic profiling of weight‑loss agents
- Safety and tolerability in metabolic cohorts
Across five early‑phase trials, a team of twenty investigators in Uppsala is advancing therapeutic options for metabolic disease.
Respiratory Tract Diseases
The program focuses on chronic lung illnesses like chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis, evaluating innovative treatments to preserve lung function and enhance patient quality of life.
- Inhaled drug delivery platforms
- Anti‑fibrotic therapeutic candidates
- Biomarker development for disease progression
- Safety assessments in pulmonary populations
With five active studies and twenty researchers, the Uppsala‑based site is driving forward new therapeutic strategies for respiratory health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 16 therapeutic areas and 15 of 93 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 93 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 18 by active trials.
- 1Boehringer Ingelheim Espana S.A.2active
lock +17 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Boehringer Ingelheim Espana S.A.5trials
lock +13 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CTC Clinical Trial Consultants AB
lock Showing 1 of 66 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1, Randomized, Crossover Study to Evaluate the Pharmacokinetics of Multiple Oral Dosing of CS014 Compared to Valproic Acid in Healthy Adults | Cereno Scientific AB | Phase I | Not Recruiting | May 2026 | Jul 2026 |
IMP list
lock Showing 1 of 93 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amlitelimab | 3 | Unknown | 2024-05-16 | 2024-10-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.